Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN
Liron Birimberg‐Schwartz(Shaare Zedek Medical Center), Dan Turner(Shaare Zedek Medical Center), Fiona Cameron(Royal Hospital for Children), David M. Zucker(Hebrew University of Jerusalem), Anders Pærregaard(Amager Hospital), Sanja Kolaček(University of Zagreb), Salvatore Cucchiara(Massachusetts General Hospital), Richard K. Russell(Tel Aviv University), Amichay Akriv(Hebrew University of Jerusalem), Siba Prosad Paul(Collaborative Group (United States)), David C. Wilson(University of Edinburgh), Stephan Buderus(Hebrew University of Jerusalem), Lambri Yianni(University Hospital Southampton NHS Foundation Trust), Claudio Romano(University of Messina), Iza Łazowska(Medical University of Warsaw), Johanna C. Escher(Erasmus MC - Sophia Children’s Hospital)
Cited by 74
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
|Nature Genetics|2017|1.5k
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Screening of Probiotic Activities of Forty-Seven Strains of <i>Lactobacillus</i> spp. by In Vitro Techniques and Evaluation of the Colonization Ability of Five Selected Strains in Humans
|Applied and Environmental Microbiology|1999|868